Cargando…
Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
Although posaconazole tablets show relatively low variability in pharmacokinetics (PK), the proportion of patients achieving the PK/PD target at the approved uniform dose for both prophylaxis and therapy is not satisfactory. The aim of this study was to develop a posaconazole population PK model in...
Autores principales: | Dvořáčková, Eliška, Šíma, Martin, Zajacová, Andrea, Vyskočilová, Kristýna, Kotowski, Tereza, Dunovská, Kateřina, Klapková, Eva, Havlín, Jan, Lischke, Robert, Slanař, Ondřej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525625/ https://www.ncbi.nlm.nih.gov/pubmed/37760696 http://dx.doi.org/10.3390/antibiotics12091399 |
Ejemplares similares
-
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022) -
Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients
por: Zajacova, A., et al.
Publicado: (2022) -
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
por: Havlin, Jan, et al.
Publicado: (2021) -
What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
por: Šíma, Martin, et al.
Publicado: (2021) -
LC–MS/MS quantitative analysis of phylloquinone, menaquinone-4 and menaquinone-7 in the human serum of a healthy population
por: Dunovska, Katerina, et al.
Publicado: (2019)